Spirea, a startup supported by the Accelerate Cambridge programme run by Cambridge Judge Business School’s Entrepreneurship Centre, has secured funding of £2.4 million with investments from high-profile UK and US investors.
Dr Myriam Ouberai, Chief Executive Officer at Spirea, commented: “We welcome our new investors and thank our existing investors for their continuing confidence in Spirea. With our novel approach to building ADC therapeutics, we aim to radically improve the treatment options for patients with hard-to-treat cancers. Having shown the flexibility and strength of our technology, we look forward to the next exciting stage in the development of Spirea’s ADC pipeline and to building significant strategic partnerships.”
Read the full article [finance.yahoo.com]